Clinical trial

A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

NCT01624051

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-07-01

PhasePHASE2

Study timeline

Study start (unknown)2014-07-01Date precision: month

Registry last updated2014-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Standard dosing method arm: Cisplatin (chemotherapy) dosing based on body surface areaOTHER

Experimental dosing method arm: Cisplatin (chemotherapy) dosing based on individual lean body massOTHER

Sponsors & collaborators

AHS Cancer Control Albertalead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01624051 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.